Nariné
Natural health product licensed in Canada
- Licence holder
- Atlas Innova Inc.
- NPN or DIN-HM
- 80058422
- Status
- Active licence
- Licence date
- 24 February 2015
- Revision date
- 21 August 2023
- Form
- Suppositoire
- Route of administration
- Vaginale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Lactobacillus acidophilus Source : Cellule entière | 3 Milliards d'UFC |
Non-medicinal ingredients
Carraghénine, Chlorure de potassium, Sucrose, Pullulane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | minimum: 19 years | 1 suppositoire | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides microorganisms that temporarily modify vaginal flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
None.
Source
Official Health Canada record, licence 80058422
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.